![Sean Cassidy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sean Cassidy
Direktor/Vorstandsmitglied bei
HOOA PHARPAR
Profil
Zurzeit ist Sean A. Cassidy Chief Financial Officer von Arvinas, Inc. und Chief Financial Officer von Arvinas Operations, Inc. (eine Tochtergesellschaft von Arvinas, Inc.) und Schatzmeister bei The Friends of Yale New Haven Children's Hospital. In der Vergangenheit hatte Herr Cassidy die Position des Chief Financial Officer & VP-Administration bei Renetx Bio, Inc. inne, Chief Financial Officer & Vice President bei CuraGen Corp, Director & Controller bei Deloitte & Touche LLP und Director & Controller bei 454 Life Sciences Corp. Er erwarb einen MBA und einen Bachelor-Abschluss an der University of Connecticut.
Aktive Positionen von Sean Cassidy
| Unternehmen | Position | Beginn |
|---|---|---|
| HOOA PHARPAR | Direktor/Vorstandsmitglied | 22.07.2024 |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Finanzdirektor/CFO | - |
The Friends of Yale New Haven Children's Hospital | Treasurer | - |
Abbratech, Inc.
 Abbratech, Inc. BiotechnologyHealth Technology Develops antibodies | Direktor/Vorstandsmitglied | - |
Renetx Bio, Inc.
 Renetx Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops disease modifying therapeutics | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Sean Cassidy
| Unternehmen | Position | Ende |
|---|---|---|
| ARVINAS, INC. | Finanzdirektor/CFO | 29.02.2024 |
Renetx Bio, Inc.
Renetx Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops disease modifying therapeutics | Finanzdirektor/CFO | 01.06.2013 |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Finanzdirektor/CFO | 01.10.2009 |
454 Life Sciences Corp.
 454 Life Sciences Corp. Medical/Nursing ServicesHealth Services Provides medical testing services to determine the nucleotide sequence of whole genomes | Direktor/Vorstandsmitglied | 01.12.2008 |
| ░░░░░░░░ ░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Sean Cassidy
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
99
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
Renetx Bio, Inc.
Renetx Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops disease modifying therapeutics | Health Technology |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Health Technology |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
454 Life Sciences Corp.
454 Life Sciences Corp. Medical/Nursing ServicesHealth Services Provides medical testing services to determine the nucleotide sequence of whole genomes | Health Services |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
The Friends of Yale New Haven Children's Hospital | |
HOOKIPA Pharma, Inc.
 HOOKIPA Pharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company which develops pharmaceutical products for immunotherapeutics targeting infectious diseases and cancers | Health Technology |
Abbratech, Inc.
Abbratech, Inc. BiotechnologyHealth Technology Develops antibodies | Health Technology |
